Jintong Wu

Ms. Jintong Wu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Journal of Immunology Research
Verified
Journal Article
Open access
ZTZijie Tang
Zijie Tang
JWJintong Wu
Jintong Wu
MDMeihan Dong
Meihan Dong
CLChengxin Li
Chengxin Li
RWRui Wang
Rui Wang
Psoriasis is a chronic, immune‐mediated inflammatory disease with systemic manifestations that include renal complications. Immunoglobulin A nephropathy (IgAN) represents the most common autoimmune glomerular disease worldwide. Growing epidemiological and genetic evidence supports a clinically relevant association between psoriasis and IgAN, particularly in patients with moderate‐to‐severe or arthropathic psoriasis. However, current knowledge remains limited by heterogeneous observational data and the absence of systematic renal screening in most psoriasis clinical trials. This review synthesizes evidence linking psoriasis and IgAN across multiple levels. Mendelian randomization studies point to a shared genetic basis, and transcriptomic analyses have uncovered overlapping immune signatures. Several inflammatory pathways may drive the production of galactose‐deficient IgA1 (Gd‐IgA1) and facilitate glomerular immune complex deposition. Aberrant IgA1 glycosylation driven by psoriatic inflammation, together with tonsillar immune activation, is proposed as a key connection between skin and kidney disease. Important knowledge gaps persist. Routine urinalysis is not performed in most psoriasis trials. Tonsillectomy data derive largely from East Asian populations, and no large‐scale international registries are currently available. We therefore propose a clinical screening framework and advocate for the establishment of dedicated registries, along with the integration of urinary tests into future trials. Addressing these gaps will enable mechanism‐based, personalized management of psoriasis‐associated IgAN.

5 May 2025 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
JWJintong Wu
Jintong Wu
ZTZijie Tang
Zijie Tang
SWSu Wang
Su Wang
YQYuxin Qiu
Yuxin Qiu
XNXinyu Nie
Xinyu Nie
RWRui Wang
Rui Wang

23 July 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
YWYilin Wang
Yilin Wang
JWJintong Wu
Jintong Wu
ZTZijie Tang
Zijie Tang
RWRui Wang
Rui Wang
CLChengxin Li
Chengxin Li
Background: Keloid treatment is a pressing challenge in clinical practice. We aim to comprehensively summarize the knowledge structure, research topics, and research trends. Methods: This study retrieved articles published between 1995 and 2025 from the Science Citation Index Expanded within the Web of Science Core Collection. Additionally, clinical trials indexed in PubMed were selected to evaluate progress in clinical research. Using bibliometric analysis tools and methods, such as VOSviewer, Scimago Graphica, and CiteSpace, we systematically explored the current research landscape. Results: China has the most significant number of articles, and the Chinese Academy of Medical Sciences and Peking Union Medical College are the most productive institutions. Bayat, A, is the most prolific author. Co‐citation clustering analysis identified research clusters encompassing molecular pathway analysis, comprehensive management and clinical guidelines, pathogenesis and fibroblast research, genetic susceptibility, synergistic drug delivery, photodynamic therapy, and novel compound therapies. Keyword burst analysis highlights the field's comprehensive advancement toward precision targeting, evidence‐based medicine, and renewed understanding of disease essence. Conclusions: Overall, this study indicates that keloid treatment focuses on precision targeting and systemic management, with frontiers expanding to delivery systems, molecular biomarkers, extracellular vesicles, metabolic reprogramming, and evidence‐based management centered on guidelines and quality of life. Novel and combined treatment approaches require further exploration.

23 October 2026 in Expert Opinion on Biological Therapy
Verified
Journal Article
Closed access
ZTZijie Tang
Zijie Tang
JWJintong Wu
Jintong Wu
CLChengxin Li
Chengxin Li
RWRui Wang
Rui Wang

1 January 2026 in Dermatologic Therapy
Verified
Journal Article
Open access
JWJintong Wu
Jintong Wu
ZTZijie Tang
Zijie Tang
SWSu Wang
Su Wang
YQYuxin Qiu
Yuxin Qiu
CLChengxin Li
Chengxin Li
RWRui Wang
Rui Wang
Background: Plasma applications can lead to effective therapy for numerous skin diseases. We aim to systematically review the available data and map the plasma medicine in dermatology. Methods: Publications relevant to plasma medicine in dermatology, published from 1996 to 2024, were retrieved from the Science Citation Index‐Expanded of the Web of Science Core Collection. Visual maps were conducted regarding annual production, collaborating countries or institutions, productive authors, core journals, co‐cited references, and keyword bursts. Results: 460 articles were identified, and the number of publications has increased rapidly since 2008. Germany was the most influential country. Leibniz Institute for Plasma Science and Technology was the most productive institution. Weltmann, K. D. was the most prolific author. Wound healing, air plasma, dielectric barrier discharge, cold atmospheric plasma (CAP), antimicrobial, antifungal, argon plasma, plasma physical parameters, nitric oxide, and transdermal drug delivery were the top 10 clusters in the cocitation cluster analysis. Keyword burst analysis suggests that current research hotspots include CAP, nonthermal plasma, expression, and apoptosis. Conclusion: This study provides an overview of plasma sources and their applications in dermatology. Plasma mechanisms and effects are currently hot topics. Most plasma applications focus on wound healing, infectious skin diseases, immune‐mediated skin diseases, and skin cancer. The parameter settings and treatment protocols of plasma for various skin diseases require further exploration. The present study maps the research landscape of CAP in dermatology and identifies directions for future investigation.